AVEO Oncology's Series B Round

AVEO Oncology raised a round of funding on October 10, 2003.

AVEO Oncology, formerly AVEO Pharmaceuticals, has built inducible, tissue-specific in vivo cancer models with which to discover drugs. Each model contains signature genetic mutations, and natural gene…

Articles about AVEO Oncology's Series B Round: